Literature DB >> 30740763

Five-year trends in acetaminophen use exceeding the recommended daily maximum dose.

David W Kaufman1, Judith P Kelly1, Deena R Battista2, Mary K Malone3, Rachel B Weinstein4, Saul Shiffman2,5.   

Abstract

Temporal patterns of acetaminophen use exceeding the recommended daily maximum dosage of 4 g over a 5-year period (4/1/2011-3/31/2016) were evaluated in an online 1-week diary study of 14 434 adult acetaminophen users who also reported acetaminophen use in the previous month. Specific medications taken were identified by list-based prompting; respondents were not required to know their medications contained acetaminophen. Details of use were recorded daily; total daily dosage was determined programmatically. Prevalence of >4 g use over time was modelled and tested for linear changes. The overall prevalence of >4 g use (6.3% of users and 3.7% of usage days) did not change over the 5 years: odds ratio (OR) persons, 1.02 (95% CI, 0.98-1.09); OR days, 0.98 (0.92-1.05). Deviations from label directions were largely unchanged, though concomitant use increased slightly. Thus, over a recent 5-year period, there was no evidence of change in how often acetaminophen use exceeded the labelled maximum daily dose.
© 2019 The British Pharmacological Society.

Entities:  

Keywords:  acetaminophen; dosing behaviour; drug safety; epidemiology; time trends

Mesh:

Substances:

Year:  2019        PMID: 30740763      PMCID: PMC6475729          DOI: 10.1111/bcp.13894

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors.

Authors:  E D Riley; R E Chaisson; T J Robnett; J Vertefeuille; S A Strathdee; D Vlahov
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

2.  Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology.

Authors:  C F Turner; L Ku; S M Rogers; L D Lindberg; J H Pleck; F L Sonenstein
Journal:  Science       Date:  1998-05-08       Impact factor: 47.728

3.  National surveillance of emergency department visits for outpatient adverse drug events.

Authors:  Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

4.  Prevalence of exceeding maximum daily dose of paracetamol, and seasonal variations in cold-flu season.

Authors:  Saul Shiffman; Deena R Battista; Judith P Kelly; Mary K Malone; Rachel B Weinstein; David W Kaufman
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

5.  Patterns of acetaminophen medication use associated with exceeding the recommended maximum daily dose.

Authors:  Saul Shiffman; Jeffrey M Rohay; Deena Battista; Judith P Kelly; Mary K Malone; Rachel B Weinstein; David W Kaufman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-07-07       Impact factor: 2.890

6.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.

Authors:  David W Kaufman; Judith P Kelly; Lynn Rosenberg; Theresa E Anderson; Allen A Mitchell
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

7.  Prevalence and correlates of exceeding the labeled maximum dose of acetaminophen among adults in a U.S.-based internet survey.

Authors:  David W Kaufman; Judith P Kelly; Jeffrey M Rohay; Mary Kathryn Malone; Rachel B Weinstein; Saul Shiffman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-09-24       Impact factor: 2.890

8.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

9.  Consumer Healthcare Products Association response to Major et al., "Trends in rates of acetaminophen-related adverse events in the United States", Pharmacoepidemiology & Drug Safety, May 2016, 25: 590-8.

Authors:  Jay E Sirois
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-03       Impact factor: 2.890

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels.

Authors:  Stephen Ph Alexander; John A Peters; Eamonn Kelly; Neil V Marrion; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

View more
  2 in total

1.  High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats.

Authors:  Junzhi Yang; Robert D Betterton; Erica I Williams; Joshua A Stanton; Elizabeth S Reddell; Chidinma E Ogbonnaya; Emma Dorn; Thomas P Davis; Jeffrey J Lochhead; Patrick T Ronaldson
Journal:  Pharmaceutics       Date:  2022-04-27       Impact factor: 6.525

2.  Impact of acetaminophen product labelling changes in Canada on hospital admissions for accidental acetaminophen overdose: a population-based study.

Authors:  Tony Antoniou; Qi Guan; Diana Martins; Tara Gomes
Journal:  CMAJ       Date:  2022-04-19       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.